Lexaria Net Income from 2010 to 2024

LEXXW Stock  USD 0.80  0.05  6.67%   
Lexaria Bioscience Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2024. During the period from 2010 to 2024, Lexaria Bioscience Net Loss regression line of quarterly data had r-squared of  0.72 and coefficient of variation of (76.49). View All Fundamentals
 
Net Loss  
First Reported
2005-11-30
Previous Quarter
-1.8 M
Current Value
-2.2 M
Quarterly Volatility
768.9 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Net Income Growth Pattern

Below is the plot of the Net Income of Lexaria Bioscience Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Lexaria Bioscience Corp financial statement analysis. It represents the amount of money remaining after all of Lexaria Bioscience Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Lexaria Bioscience's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (5.81 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Lexaria Net Income Regression Statistics

Arithmetic Mean(3,324,166)
Coefficient Of Variation(76.49)
Mean Deviation2,239,092
Median(2,504,302)
Standard Deviation2,542,773
Sample Variance6.5T
Range7.2M
R-Value(0.85)
Mean Square Error2T
R-Squared0.72
Significance0.000065
Slope(482,269)
Total Sum of Squares90.5T

Lexaria Net Income History

2024-5.5 M
2023-5.8 M
2022-6.7 M
2021-7.3 M
2020-2.5 M
2019-4 M
2018-4.2 M

Other Fundumenentals of Lexaria Bioscience Corp

Lexaria Bioscience Net Income component correlations

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-5.8 M-5.5 M
Net Loss-3.5 M-3.7 M
Net Loss-6 M-6.3 M
Net Loss(0.47)(0.07)
Net Income Per E B T 1.00  1.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.